Financial insights of BLCO

MyFinsight

For the year ending 2025-12-31, BLCO made $5,101M in revenue. -$360M in net income. Net profit margin of -7.06%.

Income Overview

Revenue
$5,101M
Net Income
-$360M
Net Profit Margin
-7.06%
EPS
-$1.02
Unit: Million (M) dollars
Revenue Breakdown
Vision Care
Pharmaceuticals
Surgical
Revenue Breakdown
Device Products
Overthe Counter Products
Pharmaceutical Products
Others
Revenue Breakdown
United Statesand Puerto Rico
Other Countries
CN
Others
Revenue Breakdown
Product
Product And Service Other

Income Statement	2025-12-31
Total revenues	5,101
Cost of goods sold (excluding amortization and impairments of intangible assets) and cost of other revenues-Product	2,045
Cost of goods sold (excluding amortization and impairments of intangible assets) and cost of other revenues-Product And Service Other	5
Selling, general and administrative (note 3)	2,234
Research and development	371
Amortization of intangible assets	258
Other expense, net	-75
Total expenses	4,988
Operating income	113
Interest income	12
Interest expense	421
Loss on extinguishment of debt	-6
Foreign exchange and other	-15
Loss before provision for income taxes	-317
Expected provision for income taxes at canadian statutory rate	-79
Domestic provincial and local income taxes, net of federal (national) income tax effect	0
Foreign tax rate differences-US	-5
Effects of cross-border taxes-US	4
Research & development tax credits-US	8
Contingent consideration fair value adjustments-US	-6
Intercompany profit in ending inventory-US	2
Other-US	4
Foreign tax rate differences-IE	49
Change in valuation allowance-IE	11
Disallowed interest-IE	17
Capital loss on sale of assets-IE	-7
Foreign exchange impact-IE	5
Intercompany profit in ending inventory-IE	-18
Other-IE	0
Change in valuation allowance-NL	4
Other-NL	1
Foreign tax rate differences-DE	-8
Other-DE	2
Foreign tax rate differences-Foreign Tax Jurisdiction Other	7
Effect of changes in tax laws or rates enacted in the current period	0
Effects of cross-border taxes-CA	2
Tax credits	0
Change in valuation allowance-CA	15
Non-deductible amount of share-based compensation	14
Disallowed interest-CA	5
Change in uncertain tax positions	0
Foreign exchange impact-CA	24
Other-CA	0
Provision for income taxes	35
Net loss	-352
Net income attributable to noncontrolling interest	8
Net loss attributable to bausch + lomb corporation	-360

Basic EPS	-1.02
Diluted EPS	-1.02
Basic Average Shares	353,800,000
Diluted Average Shares	353,800,000

MyFinsight

Income Overview

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image

Income Overview

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image